Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Cercek A, Boerner T, Tan BR, Chou JF, Gönen M, Boucher TM, Hauser HF, Do RKG, Lowery MA, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Schultz N, Kingham TP, D'Angelica MI, DeMatteo RP, Drebin JA, Allen PJ, Balachandran VP, Lim KH, Sanchez-Vega F, Vachharajani N, Majella Doyle MB, Fields RC, Hawkins WG, Strasberg SM, Chapman WC, Diaz LA Jr, Kemeny NE, Jarnagin WR.

JAMA Oncol. 2019 Oct 31. doi: 10.1001/jamaoncol.2019.3718. [Epub ahead of print]

PMID:
31670750
2.

Utilization Trends, Outcomes, and Cost in Minimally Invasive Lobectomy.

Subramanian MP, Liu J, Chapman WC Jr, Olsen MA, Yan Y, Liu Y, Semenkovich TR, Meyers BF, Puri V, Kozower BD.

Ann Thorac Surg. 2019 Aug 7. pii: S0003-4975(19)31097-5. doi: 10.1016/j.athoracsur.2019.06.049. [Epub ahead of print]

PMID:
31400324
3.

A 22-year experience with pancreatic resection for metastatic renal cell carcinoma.

Anderson B, Williams GA, Sanford DE, Lu J, Dageforde LA, Hammill CW, Fields RC, Hawkins WG, Strasberg SM, Doyle MB, Chapman WC, Khan AS.

HPB (Oxford). 2019 Jul 23. pii: S1365-182X(19)30569-6. doi: 10.1016/j.hpb.2019.05.019. [Epub ahead of print]

PMID:
31345661
4.

Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.

DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG.

Ann Surg. 2019 Mar 5. doi: 10.1097/SLA.0000000000003253. [Epub ahead of print]

PMID:
30870180
5.

The Angular Spectrum of the Scattering Coefficient Map Reveals Subsurface Colorectal Cancer.

Zeng Y, Rao B, Chapman WC Jr, Nandy S, Rais R, González I, Chatterjee D, Mutch M, Zhu Q.

Sci Rep. 2019 Feb 28;9(1):2998. doi: 10.1038/s41598-019-39146-w.

6.

Unintended consequences of changes to lung allocation policy.

Puri V, Hachem RR, Frye CC, Harrison MS, Semenkovich TR, Lynch JP, Ridolfi G, Rowe C, Meyers BF, Patterson GA, Kozower BD, Pasque MK, Nava RG, Marklin GF, Brockmeier D, Sweet SC, Chapman WC, Kreisel D.

Am J Transplant. 2019 Aug;19(8):2164-2167. doi: 10.1111/ajt.15307. Epub 2019 Mar 18.

PMID:
30758137
7.

Management of Bouveret's syndrome.

Abdallah MA, Atiq M, Kushnir V, Das KK, Doyle MB, Chapman WC, Khan AS.

J Dig Dis. 2019 Apr;20(4):215-219. doi: 10.1111/1751-2980.12713. Epub 2019 Mar 28. No abstract available.

PMID:
30756478
8.

Response to the Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR.

Ann Surg. 2019 Mar;269(3):e34-e35. doi: 10.1097/SLA.0000000000002871. No abstract available.

PMID:
30724808
9.

Racial/Ethnic Disparities in Access and Outcomes of Simultaneous Liver-Kidney Transplant Among Liver Transplant Candidates With Renal Dysfunction in the United States.

Chang SH, Wang M, Liu X, Alhamad T, Lentine KL, Schnitzler MA, Colditz GA, Park Y, Chapman WC.

Transplantation. 2019 Aug;103(8):1663-1674. doi: 10.1097/TP.0000000000002574.

PMID:
30720678
10.

Long-Term Endocrine and Exocrine Insufficiency After Pancreatectomy.

Kusakabe J, Anderson B, Liu J, Williams GA, Chapman WC, Doyle MMB, Khan AS, Sanford DE, Hammill CW, Strasberg SM, Hawkins WG, Fields RC.

J Gastrointest Surg. 2019 Aug;23(8):1604-1613. doi: 10.1007/s11605-018-04084-x. Epub 2019 Jan 22.

11.

First, Do No Harm: Rethinking Routine Diversion in Sphincter-Preserving Rectal Cancer Resection.

Chapman WC Jr, Subramanian M, Jayarajan S, Makhdoom B, Mutch MG, Hunt S, Silviera ML, Glasgow SC, Olsen MA, Wise PE.

J Am Coll Surg. 2019 Apr;228(4):547-556.e8. doi: 10.1016/j.jamcollsurg.2018.12.012. Epub 2019 Jan 9.

PMID:
30639302
12.

Hepatocellular carcinoma: Where are we in 2018?

Chapman WC, Korenblat KM, Fowler KJ, Saad N, Khan AS, Subramanian V, Doyle MBM, Dageforde LA, Tan B, Grierson P, Lin Y, Xu M, Brunt EM.

Curr Probl Surg. 2018 Nov;55(11):450-503. doi: 10.1067/j.cpsurg.2018.10.002. Epub 2018 Nov 1. Review. No abstract available.

PMID:
30526875
13.

Accounting for proximal variants improves neoantigen prediction.

Hundal J, Kiwala S, Feng YY, Liu CJ, Govindan R, Chapman WC, Uppaluri R, Swamidass SJ, Griffith OL, Mardis ER, Griffith M.

Nat Genet. 2019 Jan;51(1):175-179. doi: 10.1038/s41588-018-0283-9. Epub 2018 Dec 3.

14.

Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience.

Trikalinos NA, Zhou A, Doyle MBM, Fowler KJ, Morton A, Vachharajani N, Amin M, Keller JW, Chapman WC, Brunt EM, Tan BR.

J Natl Compr Canc Netw. 2018 Oct;16(10):1193-1199. doi: 10.6004/jnccn.2018.7053.

PMID:
30323089
15.

Thoracic Epidural Analgesia: Does It Enhance Recovery?

Rosen DR, Wolfe RC, Damle A, Atallah C, Chapman WC Jr, Vetter JM, Mutch MG, Hunt SR, Glasgow SC, Wise PE, Smith RK, Silviera ML.

Dis Colon Rectum. 2018 Dec;61(12):1403-1409. doi: 10.1097/DCR.0000000000001226.

PMID:
30308525
16.

Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model.

Vemuri C, Upadhya GA, Arif B, Jia J, Lin Y, Gaut JP, Fazal J, Pan H, Wickline SA, Chapman WC.

Transplant Direct. 2018 Aug 21;4(9):e384. doi: 10.1097/TXD.0000000000000817. eCollection 2018 Sep.

17.

Enhanced immunosuppression improves early allograft function in a porcine kidney transplant model of donation after circulatory death.

Xu M, Garcia-Aroz S, Banan B, Wang X, Rabe BJ, Zhou F, Nayak DK, Zhang Z, Jia J, Upadhya GA, Manning PT, Gaut JP, Lin Y, Chapman WC.

Am J Transplant. 2019 Mar;19(3):713-723. doi: 10.1111/ajt.15098. Epub 2018 Sep 26.

PMID:
30152136
18.

"Response to Letter to the Editor: Impact of Recurrence Surveillance on Recurrence Patterns After Resection of Hepatocellular Carcinoma".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR.

Ann Surg. 2018 Jun 28. doi: 10.1097/SLA.0000000000002871. [Epub ahead of print] No abstract available.

PMID:
29958228
19.

The importance of early recognition in management of ERCP-related perforations.

Bill JG, Smith Z, Brancheck J, Elsner J, Hobbs P, Lang GD, Early DS, Das K, Hollander T, Doyle MBM, Fields RC, Hawkins WG, Strasberg SM, Hammill C, Chapman WC, Edmundowicz S, Mullady DK, Kushnir VM.

Surg Endosc. 2018 Dec;32(12):4841-4849. doi: 10.1007/s00464-018-6235-8. Epub 2018 May 16.

PMID:
29770887
20.

Benchmarking rectal cancer care: institutional compliance with a longitudinal checklist.

Chapman WC Jr, Choi P, Hawkins AT, Hunt SR, Silviera ML, Wise PE, Mutch MG, Glasgow SC.

J Surg Res. 2018 May;225:142-147. doi: 10.1016/j.jss.2018.01.006. Epub 2018 Feb 21.

21.

Utility of Endoscopic Ultrasound in Evaluating Local Recurrence After Surgery for Pancreatic Cancer.

Lang GD, Mullady DK, Early DS, Hollander T, Edmundowicz SA, Murad FM, Strasberg SM, Fields RC, Hawkins WG, Doyle MB, Chapman WC, Wang-Gillam A, Kushnir VM.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1834-1835. doi: 10.1016/j.cgh.2018.02.031. Epub 2018 Mar 2.

PMID:
29505906
22.

Cost Evaluation of a Donation after Cardiac Death Program: How Cost per Organ Compares to Other Donor Types.

Lindemann J, Dageforde LA, Vachharajani N, Stahlschmidt E, Brockmeier D, Wellen JR, Khan A, Chapman WC, Doyle MM.

J Am Coll Surg. 2018 May;226(5):909-916. doi: 10.1016/j.jamcollsurg.2018.02.005. Epub 2018 Mar 2.

PMID:
29505825
23.

Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded Cohort.

Pak LM, Chakraborty J, Gonen M, Chapman WC, Do RKG, Groot Koerkamp B, Verhoef K, Lee SY, Massani M, van der Stok EP, Simpson AL; Memorial Sloan Kettering Cancer Center Hepatopancreatobiliary Service.

J Am Coll Surg. 2018 May;226(5):835-843. doi: 10.1016/j.jamcollsurg.2018.02.001. Epub 2018 Feb 15.

24.

Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review.

Khan AS, Garcia-Aroz S, Ansari MA, Atiq SM, Senter-Zapata M, Fowler K, Doyle MB, Chapman WC.

Int J Surg. 2018 Apr;52:74-81. doi: 10.1016/j.ijsu.2018.01.042. Epub 2018 Feb 7. Review.

PMID:
29425829
25.

Proposed standards for reporting outcomes of treating biliary injuries.

Cho JY, Baron TH, Carr-Locke DL, Chapman WC, Costamagna G, de Santibanes E, Dominguez Rosado I, Garden OJ, Gouma D, Lillemoe KD, Angel Mercado M, Mullady DK, Padbury R, Picus D, Pitt HA, Sherman S, Shlansky-Goldberg R, Tornqvist B, Strasberg SM.

HPB (Oxford). 2018 Apr;20(4):370-378. doi: 10.1016/j.hpb.2017.10.012. Epub 2018 Feb 4.

26.

Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma.

Brauer DG, Fields RC, Tan BR Jr, Doyle MBM, Hammill CW, Hawkins WG, Colditz GA, Chapman WC.

HPB (Oxford). 2018 May;20(5):470-476. doi: 10.1016/j.hpb.2017.11.010. Epub 2018 Jan 20.

27.

Patient and Graft Survival: Biliary Complications after Liver Transplantation.

Senter-Zapata M, Khan AS, Subramanian T, Vachharajani N, Dageforde LA, Wellen JR, Shenoy S, Majella Doyle MB, Chapman WC.

J Am Coll Surg. 2018 Apr;226(4):484-494. doi: 10.1016/j.jamcollsurg.2017.12.039. Epub 2018 Jan 31.

PMID:
29360615
28.

Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.

Sharma Y, Weaver MJ, Ludwig DR, Fowler K, Vachharajani N, Chapman WC, Crippin JS.

Surgery. 2018 May;163(5):1002-1007. doi: 10.1016/j.surg.2017.10.063. Epub 2017 Dec 25.

PMID:
29284589
29.

Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.

Krasnick BA, Jin LX, Davidson JT 4th, Sanford DE, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Hawkins WG, Chapman WC, Doyle MBM, Weber SM, Strasberg SM, Salem A, Martin RCG, Isom CA, Scoggins C, Schmidt CR, Shen P, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.

J Surg Oncol. 2018 Mar;117(3):363-371. doi: 10.1002/jso.24836. Epub 2017 Dec 28.

30.

Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.

Schimizzi GV, Jin LX, Davidson JT 4th, Krasnick BA, Ethun CG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Weber SM, Salem A, Hawkins WG, Strasberg SM, Doyle MB, Chapman WC, Martin RCG, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.

HPB (Oxford). 2018 Apr;20(4):332-339. doi: 10.1016/j.hpb.2017.10.003. Epub 2017 Nov 21.

31.

Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience.

Dominguez-Rosado I, Fields RC, Woolsey CA, Williams G, Horwedel TA, Rose JB, Hammill CW, Doyle MB, Chapman WC, Strasberg SM, Hawkins WG, Sanford DE.

J Am Coll Surg. 2018 Feb;226(2):147-154.e1. doi: 10.1016/j.jamcollsurg.2017.10.021. Epub 2017 Nov 11.

PMID:
29133263
32.

Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death.

Xu M, Wang X, Banan B, Chirumbole DL, Garcia-Aroz S, Balakrishnan A, Nayak DK, Zhang Z, Jia J, Upadhya GA, Gaut JP, Hiebsch R, Manning PT, Wu N, Lin Y, Chapman WC.

Am J Transplant. 2018 Apr;18(4):855-867. doi: 10.1111/ajt.14567. Epub 2017 Dec 2.

33.

Response: "Which is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?"

Agopian VG, Chapman WC, Busuttil RW; United States Multicenter Hepatocellular Carcinoma Transplant Consortium (UMHTC).

Ann Surg. 2018 Dec;268(6):e57-e60. doi: 10.1097/SLA.0000000000002577. No abstract available.

PMID:
29064906
34.

Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.

Ethun CG, Lopez-Aguiar AG, Anderson DJ, Adams AB, Fields RC, Doyle MB, Chapman WC, Krasnick BA, Weber SM, Mezrich JD, Salem A, Pawlik TM, Poultsides G, Tran TB, Idrees K, Isom CA, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Cardona K, Maithel SK.

Ann Surg. 2018 May;267(5):797-805. doi: 10.1097/SLA.0000000000002574.

35.

Surgeon Variation in Intraoperative Supply Cost for Pancreaticoduodenectomy: Is Intraoperative Supply Cost Associated with Outcomes?

Brauer DG, Ohman KA, Jaques DP, Woolsey CA, Wu N, Liu J, Doyle MBM, Fields RC, Chapman WC, Strasberg SM, Hawkins WG.

J Am Coll Surg. 2018 Jan;226(1):37-45.e1. doi: 10.1016/j.jamcollsurg.2017.10.007. Epub 2017 Oct 19.

36.

CD47 blockade reduces ischemia/reperfusion injury in donation after cardiac death rat kidney transplantation.

Wang X, Xu M, Jia J, Zhang Z, Gaut JP, Upadhya GA, Manning PT, Lin Y, Chapman WC.

Am J Transplant. 2018 Apr;18(4):843-854. doi: 10.1111/ajt.14523. Epub 2017 Nov 1.

37.

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.

Zheng J, Chakraborty J, Chapman WC, Gerst S, Gonen M, Pak LM, Jarnagin WR, DeMatteo RP, Do RKG, Simpson AL; Hepatopancreatobiliary Service in the Department of Surgery of the Memorial Sloan Kettering Cancer Center; Research Staff in the Department of Surgery at Washington University School of Medicine.

J Am Coll Surg. 2017 Dec;225(6):778-788.e1. doi: 10.1016/j.jamcollsurg.2017.09.003. Epub 2017 Sep 21.

38.

Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.

Muller X, Marcon F, Sapisochin G, Marquez M, Dondero F, Rayar M, Doyle MMB, Callans L, Li J, Nowak G, Allard MA, Jochmans I, Jacskon K, Beltrame MC, van Reeven M, Iesari S, Cucchetti A, Sharma H, Staiger RD, Raptis DA, Petrowsky H, de Oliveira M, Hernandez-Alejandro R, Pinna AD, Lerut J, Polak WG, de Santibañes E, de Santibañes M, Cameron AM, Pirenne J, Cherqui D, Adam RA, Ericzon BG, Nashan B, Olthoff K, Shaked A, Chapman WC, Boudjema K, Soubrane O, Paugam-Burtz C, Greig PD, Grant DR, Carvalheiro A, Muiesan P, Dutkowski P, Puhan M, Clavien PA.

Ann Surg. 2018 Mar;267(3):419-425. doi: 10.1097/SLA.0000000000002477.

39.

Challenges in patient selection for liver resection or transplantation in patients with hepatocellular carcinoma beyond Milan criteria.

Zaydfudim VM, Chapman WC, Nagorney DM.

Hepatobiliary Surg Nutr. 2017 Aug;6(4):287-289. doi: 10.21037/hbsn.2017.07.04. No abstract available.

40.

Reexamining the Association of Body Mass Index With Overall Survival Outcomes After Liver Transplantation.

Chang SH, Liu X, Carlsson NP, Park Y, Colditz GA, Garonzik-Wang JM, Chapman WC, Wellen JR, Doyle MB, Alhamad T.

Transplant Direct. 2017 Jun 12;3(7):e172. doi: 10.1097/TXD.0000000000000681. eCollection 2017 Jul.

41.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW.

Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381.

PMID:
28654545
42.

Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.

Zheng J, Chou JF, Gönen M, Vachharajani N, Chapman WC, Majella Doyle MB, Turcotte S, Vandenbroucke-Menu F, Lapointe R, Buettner S, Groot Koerkamp B, Ijzermans JNM, Chan CY, Goh BKP, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, Chung AYF, Chow PKH, Ooi LLPJ, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Lee SY.

Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.

PMID:
28650354
43.

Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection.

Gunasekaran M, Vachharajani N, Gaut JP, Maw TT, Delos Santos R, Shenoy S, Chapman WC, Wellen J, Mohanakumar T.

Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.13009. Epub 2017 Jun 21.

PMID:
28639386
44.

LI-RADS and transplantation for hepatocellular carcinoma.

Tang A, Fowler KJ, Chernyak V, Chapman WC, Sirlin CB.

Abdom Radiol (NY). 2018 Jan;43(1):193-202. doi: 10.1007/s00261-017-1210-8. Review.

PMID:
28612162
45.

Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, Woo M, Engleman EG, Adeyi O, Hirano N, Jin T, Gehring AJ, Winer S, Winer DA.

Sci Immunol. 2017 Apr 21;2(10). pii: eaai7616. doi: 10.1126/sciimmunol.aai7616.

46.

Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.

Xu M, Doyle MM, Banan B, Vachharajani N, Wang X, Saad N, Fowler K, Brunt EM, Lin Y, Chapman WC.

J Am Coll Surg. 2017 Jul;225(1):28-40. doi: 10.1016/j.jamcollsurg.2017.03.015. Epub 2017 Apr 9. Erratum in: J Am Coll Surg. 2018 Jan;226(1):115.

47.

Liver Transplantation for Malignant Primary Pediatric Hepatic Tumors.

Khan AS, Brecklin B, Vachharajani N, Subramanian V, Nadler M, Stoll J, Turmelle Y, Lowell JA, Chapman WC, Doyle MM.

J Am Coll Surg. 2017 Jul;225(1):103-113. doi: 10.1016/j.jamcollsurg.2017.02.006. Epub 2017 Feb 20.

PMID:
28232059
48.

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.

Chapman WC, Brown RS Jr, Chavin KD, Sudan D, Koneru B, Junge G, Dong G, Patel D, Teperman L, Fung JJ.

Transplantation. 2017 Feb;101(2):341-349. doi: 10.1097/TP.0000000000001524.

49.

Cutting Edge: Human CD49e- NK Cells Are Tissue Resident in the Liver.

Aw Yeang HX, Piersma SJ, Lin Y, Yang L, Malkova ON, Miner C, Krupnick AS, Chapman WC, Yokoyama WM.

J Immunol. 2017 Feb 15;198(4):1417-1422. doi: 10.4049/jimmunol.1601818. Epub 2017 Jan 16.

50.

Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.

Chapman WC, Garcia-Aroz S, Vachharajani N, Fowler K, Saad N, Lin Y, Wellen J, Tan B, Khan AS, Doyle MB.

J Am Coll Surg. 2017 Apr;224(4):610-621. doi: 10.1016/j.jamcollsurg.2016.12.020. Epub 2017 Jan 6.

PMID:
28069527

Supplemental Content

Loading ...
Support Center